Small business owners in the life sciences and healthcare sectors should be paying close attention to the recent advancements developed through a partnership between Microsoft and Novo Nordisk. The two organizations have introduced a hosted agent designed to facilitate secondary analysis of clinical trial data—a technology that could have significant implications for small firms involved in research and development.

In clinical research, the process often extends beyond the defined questions of a trial protocol. Medical experts frequently revisit data to ask new questions, compare various patient populations, visualize emerging trends, or pinpoint promising research directions.…